If not the deadliest, the novel coronavirus is certainly the most serious contagious disease to have crossed continents in modern times. One of the biggest challenges is screening en-masse for detection of infectious individuals. Today’s current methods are rudimentary (measuring only temperature) or very expensive and time consuming (swab test). Detecting infectious people at an early stage is key for disease control and management.
In seconds, Spinview’s revolutionary device, Pandemicam can, using a proven successful matrix of sensors, identify a wide range of symptoms to indicate infection.
Once the device is installed, unlimited tests can be performed without having to rely on consumable materials. The device is able to operate en-masse and report to a central server for infection monitoring and tracking. Accuracy is much higher than with non-contact thermometers, as the system can scan thousands of measurements per second across an entire spectrum of sensors, including, but going well beyond, only temperature.
COVID-19 is known to affect physiological parameters such as temperature, respiration, hydration, sweating, flushing and coughing. PandemiCam is a non-invasive multi-sensory device which is designed to collect information from multiple sensors to ‘read’ the COVID-19 symptom parameters in every person it scans.
Pandemicam combines the use of mathematics and artificial intelligence (AI) with pre-existing sensors into one revolutionary scanning unit enabling widespread screening with ease. The collected data is fused together by the system and feed through AI, to provide an accurate and fast detection of infectious people with far greater clarity than any single parameter test available today.
Appropriately named PandemiCam, this complex scanning system can help authorities across the globe limit the spread of COVID-19, assisting in the management of precious healthcare resources in real-time.
“Mathematics and Artificial Intelligence are two of the most effective weapons we have in the fight against the coronavirus outbreak” Dr Katarina Gospic, leading Neuroscientist
Where current single parameter tests such as temperature have to be measured individually, PandemiCam is able to screen groups of people and even scan at a distance for the safety necessitated by this particular disease. Against a city grid, PandemiCam allows for the real-time mapping of symptoms. Quick identification of hotspots allows for localised restrictions and resource allocations, reducing financial damage and human danger.
Continuous en-masse screening is key to winning the battle against coronavirus.
In the US, even if they were able to carry out 100,000 tests per day, in order to cover the entire population of those over the age of 18 (330 million) it would take 7 years.
The more we can repeatedly screen population(s), the better we will be at detecting infectious people and thus slowing and limiting the rate of spread.
Spinview’s screening would bring that figure down and enable mass screening and information on its spread in seconds. The system will alert healthcare professionals to identify those in need of treatment instantly – no waiting for lab results. Medical staff can carry out predictive triage – understanding based on the data received, correlated with the known passage of the disease through the system, what a patient is likely to experience and the support they will need. The system could also be used to ensure the health and wellbeing of the general public in order to resume freedom of movement. By using the device within public transport and infrastructure systems such as airports including it as part of their security checks, it could help keep airports free of COVID-19 or other diseases. This would ensure that future outbreaks could be contained and monitored more effectively while keeping the economy going and people moving.
In simple terms, PandemiCam scans en-masse, in seconds and will save lives. For more information please contact [email protected]
Click HERE to watch a short video that will show you how PandemiCam works.